glp 1 agonists anesthesia Are Serious Risks of Semaglutide and Other GLP-1 Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia The Impact of GLP-1 Receptor
Description
Chronic high-fat feeding increases GIP and GLP-1 secretion without altering body weight

Expanding our knowledge of side effects is a crucial requirement if these drugs are going to expand beyond medical usage.

As part of this, building robust direct-to-patient delivery models will be critical to ensuring timely, reliable access, supporting adherence, and reinforcing a differentiated patient experience

The inflammation factor Looking at research done on people with obesity who take GLP-1 drugs, Henry and Pillsbury noticed that in addition to weight loss, patients saw improvements in immune function, including a decrease in inflammation

Chandel NS
In addition to these, fecal microbiota transplantation (FMT) is being extensively researched and appears to have great promise for the treatment of NAFLD/NASH [51, 53]
